Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc.
31 août 2022 17h30 HE
|
Interpace Biosciences, Inc.
Interpace Transitions to focused Molecular Diagnostics BusinessDisposition of Pharma Services Expected to Improve Operating Cash Flow by nearly $5 million Annually PARSIPPANY, NJ, Aug. 31, 2022 ...
Inspirata and Flagship Biosciences Announce New Technical Partnership and Integration at Pathology Visions 2020
27 oct. 2020 11h00 HE
|
Inspirata, Inc.
Tampa, Florida / Westminster, Colorado, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today a new technical partnership with clinical...